Literature DB >> 21457457

Effect of resveratrol on bone formation in the expanded inter-premaxillary suture: early bone changes.

T Uysal1, S Gorgulu, A Yagci, Y Karslioglu, O Gunhan, D Sagdic.   

Abstract

OBJECTIVE: The aim of this study was to evaluate the effects of local resveratrol (RSVL) administration on bone formation in response to expansion of the inter-premaxillary suture, in rats.
MATERIAL AND METHODS: Twenty 50- to 60-day-old male Wistar rats were separated into two equal groups. Both groups were subjected to expansion, and 30 cN of force was applied to the maxillary incisors with helical-spring. Twenty-four hours after appliance placement, single-dose 10 μmol/kg RSVL in the dimethylsulfoxide (DMSO) was injected to the inter-premaxillary suture in the experimental group. In the control group, the same amount of DMSO was injected to the suture of rats. Bone formation in the suture was evaluated histomorphometrically. The area of new bone (μm(2)), the perimeter around the new bone (μm), Feret's diameter (μm), the percentage of new bone to non-ossified tissue (%), and the number of osteoblast were measured and compared. Mann-Whitney U-test was used for statistical evaluation at p < 0.05 level.
RESULTS: Statistically significant differences were found between the groups for all histomorphometric parameters. New bone area (p < 0.001), bone perimeter (p < 0.001), Feret's diameter (p < 0.001), percentage of new bone (p < 0.001), and the number of osteoblast (p < 0.001) were significantly larger in the experimental group when compared with the control. Bone histomorphometric measurements revealed that bone architecture in the RSVL treated rats was improved.
CONCLUSIONS: Local application of RSVL during the early stages to orthopedically expanded inter-premaxillary suture area may stimulate bone formation and shorten the retention period, in rats.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21457457     DOI: 10.1111/j.1601-6343.2011.01511.x

Source DB:  PubMed          Journal:  Orthod Craniofac Res        ISSN: 1601-6335            Impact factor:   1.826


  7 in total

1.  A novel library screen identifies immunosuppressors that promote osteoblast differentiation.

Authors:  Ariana Darcy; Micah Meltzer; Joseph Miller; Steven Lee; Scott Chappell; Kris Ver Donck; Monty Montano
Journal:  Bone       Date:  2012-03-13       Impact factor: 4.398

2.  The effect of different concentrations of topical ozone administration on bone formation in orthopedically expanded suture in rats.

Authors:  S Kutalmış Buyuk; Sabri Ilhan Ramoglu; Mehmet Fatih Sonmez
Journal:  Eur J Orthod       Date:  2015-07-01       Impact factor: 3.075

3.  New bone-generative effect of Salvia officinalis L. in the expanded midpalatal suture : An in vivo and in vitro study.

Authors:  Emre Kayalar; Fatih Goger; Gul Tas Deynek; Olgu Enis Tok; Sevim Kucuk
Journal:  J Orofac Orthop       Date:  2022-01-11       Impact factor: 2.341

4.  Tanshinol attenuates the deleterious effects of oxidative stress on osteoblastic differentiation via Wnt/FoxO3a signaling.

Authors:  Yajun Yang; Yanjie Su; Dongtao Wang; Yahui Chen; Tie Wu; Gang Li; Xuegang Sun; Liao Cui
Journal:  Oxid Med Cell Longev       Date:  2013-12-31       Impact factor: 6.543

5.  Tanshinol Rescues the Impaired Bone Formation Elicited by Glucocorticoid Involved in KLF15 Pathway.

Authors:  Yajun Yang; Yanjie Su; Dongtao Wang; Yahui Chen; Yuyu Liu; Shiying Luo; Tie Wu; Liao Cui
Journal:  Oxid Med Cell Longev       Date:  2016-03-14       Impact factor: 6.543

Review 6.  Advance on Resveratrol Application in Bone Regeneration: Progress and Perspectives for Use in Oral and Maxillofacial Surgery.

Authors:  Denise Murgia; Rodolfo Mauceri; Giuseppina Campisi; Viviana De Caro
Journal:  Biomolecules       Date:  2019-03-08

7.  Effects of teriparatide on bone formation in rats with experimentally induced premaxillary expansion.

Authors:  Yasin Çamili; Sıddık Malkoç; Aslı Taşlidere; Zehra Ileri; Ozge Celik Guler
Journal:  Dental Press J Orthod       Date:  2022-07-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.